Six things to know:
1. Fourth-quarter revenue was $55.6 million, a 20 percent year-over-year-increase.
2. U.S. revenue grew 19 percent compared to the same time last year. Spinal implant revenue in the U.S. jumped 32 percent year over year with $27.3 million, and U.S. orthobiologics revenue grew 7 percent compared to the same time last year.
3. International revenue clocked in at $5.4 million, growing 26 percent.
4. Full-year revenue was $191.5 million, a 24 percent increase compared to 2020. U.S. revenue in 2021 increased 23 percent with $171.4 million.
5.SeaSpine’s 7D Surgical saw $6 million in sales revenue during 2021.
6. SeaSpine expects 2022 revenue to hit $226 million to $230 million, an 18 to 20 percent growth compared to 2021.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
